GHIMAS

GHIMAS is a renowned Pharmaceutical startup based in Italy, specializing in innovative injectable, oral, and topical formulations for Pharma, Aesthetics, and Dental applications. The company has a rich history, being established in 1947 and has since then, developed a wide portfolio of products. With a robust sales network spanning over 40 countries globally, GHIMAS has established itself as a key player in the industry. In 2021, GHIMAS became a part of the US-based group AAT, leveraging this partnership to cater to its national and international clients from the production site located in Bologna, Italy. With no information available regarding the last investment and investors, GHIMAS stands as a compelling prospect for potential venture capital investment. With its strong legacy and innovative solutions, GHIMAS presents an intriguing opportunity for investors seeking a foothold in the pharmaceutical industry.